Ad is loading...

VIRX Viracta Therapeutics Forecast, Technical & Fundamental Analysis

a developer of oncology therapeutics for treatment of solid and hematologic cancers

Industry Biotechnology

Get AI intraday signals

VIRX

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if shorted

View Trends For VIRX
(Try 14 days for Free)

View a ticker or compare two or three

Compare

VIRX

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if shorted

View Trends For VIRX
(Try 14 days for Free)

Ad is loading...

A.I. Advisor

published Earnings

VIRX is expected to report earnings to fall 29.63% to -18 cents per share on March 18

Viracta Therapeutics VIRX Stock Earnings Reports

Q4'24

Est.

$-0.19

Q3'24

Est.

$-0.27

Q2'24

Beat

by $0.12

Q1'24

Beat

by $0.12

Q4'23

Missed

by $0.04

The last earnings report on November 13 showed earnings per share of -27 cents, meeting the estimate of -27 cents. With 1.15M shares outstanding, the current market capitalization sits at 5.95M.

A.I. Advisor

published General Information

General Information

a developer of oncology therapeutics for treatment of solid and hematologic cancers

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Biotechnology

Address

2533 South Coast Highway 101

Phone

+1 858 400-8470

Employees

Web

https://www.viracta.com

Interesting Tickers

STOCK / NAME	Price $	Chg $	Chg %
		1 Day
ALLY	36.22	N/A	N/A
Ally Financial
CRESY	10.81	-0.04	-0.37%
Cresud S.A.C.I.F. y A.
PINC	22.48	-0.27	-1.19%
Premier
THM	0.42	-0.02	-3.48%
International Tower Hill Mines Ltd
CMND	1.34	-0.13	-8.84%
Clearmind Medicine

VIRX and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, VIRX has been loosely correlated with MDGL. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if VIRX jumps, then MDGL could also see price increases.

Ticker / NAME	Correlation To VIRX	1D Price Change %
VIRX	100%	-4.37%
MDGL - VIRX	38% Loosely correlated	-4.66%
CHRS - VIRX	34% Loosely correlated	-3.70%
MRNS - VIRX	31% Poorly correlated	-2.24%
AXON - VIRX	30% Poorly correlated	-0.86%
CYTK - VIRX	30% Poorly correlated	-8.19%
More